Skip to content

Spectral CT Clinical Trial Protocol

Spectral CT Clinical Trial Protocol

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05017233
Enrollment
51
Registered
2021-08-23
Start date
2022-07-04
Completion date
2023-02-12
Last updated
2024-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT Scanning

Brief summary

The purpose of this study was to evaluate the expected effectiveness, ease of operation, stability, and safety of Spectral CT

Detailed description

Under the premise of protecting subjects and ensuring the scientific nature of this study, Spectral CT was evaluated for its effectiveness, convenience, stability and safety under normal conditions by collecting clinical cases.

Interventions

Using Spectral CT to scan Breast

Sponsors

Shanghai Changzheng Hospital
CollaboratorOTHER
Ruijin Hospital
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
Philips (China) Investment CO., LTD
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Recruit volunteers (ages 18 to 75); * Negative pregnancy tests in women of childbearing age; * Participants who agree to participate in this clinical trial and sign the informed consent; * Enhanced scans require laboratory tests to confirm normal renal function.

Exclusion criteria

* Persons who do not have full capacity for civil conduct; * Lactating women; * People who are not suitable for enhanced scanning with iodine contrast agent; * Patients whom the investigator considers inappropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Excellent and good rate of clinical imaging (score≥3)through study completion, an average of 1 yearRated items 5 points Excellent image quality for diagnostic purposes, very satisfactory 4 points good image quality, can be used for diagnosis, satisfactory 3 points Image quality defects, do not affect the diagnosis, general 2. Unsatisfactory image quality, affecting diagnosis Poor image quality, undiagnosable, unsatisfactory

Secondary

MeasureTime frameDescription
Common functions assessmentthrough study completion, an average of 1 yearCommon function evaluation items inclduing:The exposure function; Bed body moving; Microphone intercom function; Image post-processing function; Data storage management. With Satisfied, normal, Not Satisfied
Convenience evaluation assessmentthrough study completion, an average of 1 yearConvenience function evaluation items inclduing:Laser positioning lamp Breathing navigation Control buttons The clinical interface friendliness of postprocessing software The post-processing software is convenient for clinical use and operation. With Satisfied, normal, Not Satisfied
Machine function and stability assessmentthrough study completion, an average of 1 yearMachine function and stability evaluation items inclduing:workflow Image display and transmission Failed to start system Unexpected system shutdown Abnormal termination during the scan Unable to expose during scan. With Satisfied, normal, Not Satisfied
Adverse events and serious adverse eventsthrough study completion, an average of 1 yearAdverse events and serious adverse events during the test were collected to evaluate the safety of the product.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026